Pubblicazioni

ANTI-HLA DONOR SPECIFIC ANTIBODIES (DSA) IN THE TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS AND DESENSITIZATION STRATEGY. UNICENTRIC PERSPECTIVE STUDY

2019 - HAEMATOLOGICA

La Rocca, U.; Iori, A. P.; Perrone, M. P.; Cinti, P.; Gozzer, M.; Shafii, B. M.; Pepe, S.; Barberi, W.; Quattrocchi, L.; Cavallari, C.; Gesuiti, P.; Lattanzi, R.; Ricci, R.; Laurenti, L.; FoÃ , R.; Girelli, G.

Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction

2019 - HAEMATOLOGICA

Kooij, Gijs; Derada Troletti, Claudio; Leuti, Alessandro; Norris, Paul C; Riley, Ian; Albanese, Maria; Ruggieri, Serena; Libreros, Stephania; van der Pol, Susanne M A; van Het Hof, Bert; Schell, YoÃ«lle; Guerrera, Gisella; Buttari, Fabio; Mercuri, Nicola Biagio; Centonze, Diego; Gasperini, Claudio; Battistini, Luca; de Vries, Helga E; Serhan, Charles N; ChiurchiÃ¹, Valerio

Role of interferon-Î³ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation

2019 - HAEMATOLOGICA

Merli, P.; Caruana, I.; De Vito, R.; Strocchio, L.; Weber, G.; Del Bufalo, F.; Buatois, V.; Montanari, P.; Cefalo, M. G.; Pitisci, A.; Algeri, M.; Galaverna, F.; Quintarelli, C.; Cirillo, V.; Pagliara, D.; Ferlin, W.; Ballabio, M.; De Min, C.; Locatelli, F.

Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation

2019 - HAEMATOLOGICA

Mouttet, B.; Vinti, L.; Ancliff, P.; Bodmer, N.; Brethon, B.; Cario, G.; Chen-Santel, C.; Elitzur, S.; Hazar, V.; Kunz, J.; Moricke, A.; Stein, J.; Vora, A.; Yaman, Y.; Schrappe, M.; Anak, S.; Baruchel, A.; Locatelli, F.; Stackelberg, A. V.; Stanulla, M.; Bourquin, J. -P.

Risk factors and outcomes according to age at transplantation with an hla-identical sibling for sickle cell disease

2019 - HAEMATOLOGICA

Cappelli, B.; Volt, F.; Tozatto-Maio, K.; Scigliuolo, G. M.; Ferster, A.; Dupont, S.; Simoes, B. P.; Al-Seraihy, A.; Aljurf, M. D.; Almohareb, F.; Belendez, C.; Matthes, S.; Dhedin, N.; Pondarre, C.; Dalle, J. -H.; Bertrand, Y.; Vannier, J. P.; Kuentz, M.; Lutz, P.; Michel, G.; Rafii, H.; Neven, B.; Zecca, M.; Bader, P.; Cavazzana, M.; Labopin, M.; Locatelli, F.; Magnani, A.; Ruggeri, A.; Rocha, V.; Bernaudin, F.; de la Fuente, J.; Corbacioglu, S.; Gluckman, E.

ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells

2019 - HAEMATOLOGICA

Portale, F.; Cricri, G.; Bresolin, S.; Lupi, M.; Gaspari, S.; Silvestri, D.; Russo, B.; Marino, N.; Ubezio, P.; Pagni, F.; Vergani, P.; Te Kronnie, G.; Valsecchi, M. G.; Locatelli, F.; Rizzari, C.; Biondi, A.; Dander, E.; D'Amico, G.

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

2019 - HAEMATOLOGICA

Fava, Carmen; Rege-Cambrin, Giovanna; Dogliotti, Irene; Cerrano, Marco; Berchialla, Paola; Dragani, Matteo; Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Martino, Bruno; Gambacorti-Passerini, Carlo; Abruzzese, Elisabetta; Elena, Chiara; Pregno, Patrizia; Gozzini, Antonella; Capodanno, Isabella; Bergamaschi, Micaela; Crugnola, Monica; Bocchia, Monica; Galimberti, Sara; Rapezzi, Davide; Iurlo, Alessandra; Cattaneo, Daniele; Latagliata, Roberto; Breccia, Massimo; Cedrone, Michele; Santoro, Marco; Annunziata, Mario; Levato, Luciano; Stagno, Fabio; Cavazzini, Francesco; Sgherza, Nicola; Giai, Valentina; Luciano, Luigia; Russo, Sabina; Musto, Pellegrino; Caocci, Giovanni; Sora, Federica; Iuliano, Francesco; Lunghi, Francesca; Specchia, Giorgina; Pane, Fabrizio; Ferrero, Dario; Baccarani, Michele; Saglio, Giuseppe

Acquired thrombotic thrombocytopenic purpura in a child: Rituximab to prevent relapse. A pediatric report and literature review

2018 - HAEMATOLOGICA

Mariani, Sabrina; Trisolini, Silvia M.; Capria, Saveria; Moleti, Maria L.; Chisini, Marta; Ferrazza, Giancarlo; Bafti, Mahnaz Shafii; Limongiello, Maria A.; Miulli, Eleonora; Peyvandi, Flora; FoÃ , Robin; Testi, Anna M.

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

2018 - HAEMATOLOGICA

Cuneo, Antonio; Follows, George; Rigolin, Gian Matteo; Piciocchi, Alfonso; Tedeschi, Alessandra; Trentin, Livio; Medina Perez, Angeles; Coscia, Marta; Laurenti, Luca; Musuraca, Gerardo; Farina, Lucia; Rivas Delgado, Alfredo; Orlandi, Ester Maria; Galieni, Piero; Mauro, Francesca Romana; Visco, Carlo; Amendola, Angela; Billio, Atto; Marasca, Roberto; Chiarenza, Annalisa; Meneghini, Vittorio; Ilariucci, Fiorella; Marchetti, Monia; Molica, Stefano; Re, Francesca; Gaidano, Gianluca; Gonzalez, Marcos; Forconi, Francesco; Ciolli, Stefania; Cortelezzi, Agostino; Montillo, Marco; Smolej, Lukas; Schuh, Anna; Eyre, Toby A; Kennedy, Ben; Bowles, Kris M; Vignetti, Marco; de la Serna, Javier; Moreno, Carol; FoÃ , Robin; Ghia, Paolo

Development of a combination strategy based on ER and oxidativa stress to target acute myeloid leukemia

2018 - HAEMATOLOGICAHAEMATOLOGICA

Masciarelli, Silvia; Capuano, E.; Ottone, T.; Divona, M.; Lavorgna, S.; Picardi, A.; Voso, M. T.; Lo-Coco, F.; Fazi, Francesco

Prognostic implications of additional genomic lesions in adult Ph+ acute lymphoblastic leukemia

2018 - HAEMATOLOGICA

Fedullo, Al; Messina, M; Elia, L; Piciocchi, A; Gianfelici, V; Lauretti, A; Soddu, S; Puzzolo, Mc; Minotti, C; Ferrara, F; Martino, B; Chiusolo, P; Calafiore, V; Paolini, S; Vignetti, M; Vitale, A; Guarini, A; FoÃ , R; Chiaretti, S.

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the Phase 3b GREEN study

2018 - HAEMATOLOGICA

Leblond, V; Aktan, M; Ferra Coll CM, ; Dartigeas, C; Kisro, J; Montillo, M; Raposo, J; Merot, Jl; Robson, S; Gresko, E; Bosch, F; Stilgenbauer, S; FoÃ , R

Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells

2018 - HAEMATOLOGICA

Spagnuolo, Manuela; Regazzo, Giulia; De Dominici, Marco; Sacconi, Andrea; Pelosi, Andrea; Korita, Etleva; Marchesi, Francesco; Pisani, Francesco; Magenta, Alessandra; Lulli, Valentina; Cordone, Iole; Mengarelli, Andrea; Strano, Sabrina; Blandino, Giovanni; Rizzo, Maria G; Calabretta, Bruno

A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis.

2018 - HAEMATOLOGICA

Quattrocchi, Alberto; Tomassini, Simona; Billi, M.; Scerpa, Mc.; Cenfra, N.; Gentile, Martina; Maiorca, Carlo; Ceccherelli, A.; De Marinis, E.; Grignani, F.; Cimino, G.; Nervi, C.

TARGETING SIGLEC-7: A NOVEL IMMUNOTHERAPEUTIC APPROACH TO POTENTIATE THE CYTOTOXIC FUNCTIONS OF NATURAL KILLER CELLS AGAINST MULTIPLE MYELOMA

2018 - HAEMATOLOGICA

Daly, J; Sarkar, S; Natoni, A; Hu, J; Chauhan, S; Henderson, R; Duggan, T; Mccarthy, Pl; Mcellistrim, C; O'Dwyer, M

Low dose cyclophosphamide potentiates the anti-myeloma activity of daratumumab through augmentation of macrophage-induced ADCP

2018 - HAEMATOLOGICA

S, Naicker; A, Rigalou; C, Mcellistrim; R, Henderson; Natoni, Alessandro; C, Chiu; K, Sasser; A, Ryan; M, O'Dwyer

Novel kinase inhibitors afuresertib and PIM447 are active alone and in combination with standard therapies, respectively, in a predictive MM in vivo model, and a CRISPR genome-wide screening approach identifies clinically-relevant biomarkers determining susceptibility to these therapeutic strategies

2018 - HAEMATOLOGICA

N, Keane; Natoni, Alessandro; M, Sharik; M, Chesi; Pl, Bergsagel; M, O'Dwyer

Melphalan 140mg/M2 Or 200mg/M2 For Autologous Transplantation In Myeloma: Results From The Collaboration To Collect Autologous Transplant Outcomes In Lymphoma And Myeloma (CALM) Study. A Report By The EBMT Chronic Malignancies Working Party

2018 - HAEMATOLOGICA

Auner, Hw; Iacobelli, S; Sbianchi, G; Knol-Bout, C; Blaise, D; Russell, Nh; Apperley, Jf; Pohlreich, D; Browne, P; Kobbe, G; Isaksson, C; Lenhoff, S; Scheid, C; Touzeau, C; Jantunen, E; Anagnostopoulos, A; Yakoub-Agha, I; Tanase, A; Schaap, N; Wiktor-Jedrzejczak, W; Krejci, M; SchÃ¶nland, So; Morris, C; Garderet, L; KrÃ¶ger, N.

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the chronic malignancies working party of the EBMT

2018 - HAEMATOLOGICA

Gagelmann, N; Eikema, Dj; Iacobelli, S; Koster, L; Nahi, H; Stoppa, Am; Masszi, T; Caillot, D; Lenhoff, S; Udvardy, M; Crawley, C; Arcese, W; Mariette, C; Hunter, A; Leleu, X; Schipperus, M; Delforge, M; Pioltelli, P; Snowden, Ja; ItÃ¤lÃ¤-Remes, M; Musso, M; van Biezen, A; Garderet, L; KrÃ¶ger, N

RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS

2017 - HAEMATOLOGICA

Santoro, Cristina; Massaro, Fulvio; Baldacci, Erminia; Ferrara, G.; Malaspina, Francesco; Santoro, Rc; Pasca, S.; Castaman, G.; Peyvandi, F.; Foa, Roberto; Mazzucconi, Maria Gabriella

VALIDATION OF THE REVISED IPSET-THROMBOSIS SCORE IN 734 PATIENTS WITH WHO 2016-DEFINED ESSENTIAL THROMBOCYTHEMIA. REPORT OF THE REGISTRO ITALIANO TROMBOCITEMIE

2017 - HAEMATOLOGICA

Gugliotta, L; Iurlo, A; Gugliotta, G; Tieghi, A; Gaidano, G; Dragani, A; Scalzulli, P; Martinelli, V; Martino, B; Randi, Ml; Appolloni, V; Maschio, N; Langella, M; Santoro, Cristina; Rago, A; Cacciola, E; Cacciola, R; Caocci, G; Plebani, S; Santoro, U; Vianelli, N; Mazzucconi, Maria Gabriella; Specchia, G.

RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF A-HYPO-FIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS

2017 - HAEMATOLOGICA

Santoro, Cristina; Massaro, Fulvio; Baldacci, E; Ferrara, G; Ferretti, Antonietta; Santoro, Rc; Pasca, S; Castaman, G; Peyvandi, F; Foa, Roberto; Mazzucconi, Maria Gabriella

IS THE SURVIVAL OF PATIENTS WITH ESSENTIAL THROMBOCYTEMIA BETTER IN THE LAST DECADE? RETROSPECTIVE ANALYSIS OF DATABASE OF LATIAL GROUP FOR THE STUDY OF NMP, PH NEGATIVE

2017 - HAEMATOLOGICA

Montanaro, M; Andriani, A; Cedrone, M; Santoro, Cristina; Spirito, F; Crescenzi, Sl; Porrini, R; Di Veroli, A; Villiva, N; Spadea, A; Rago, A; De Gregoris, C; De Muro, M; Felici, S; Breccia, M; Montefusco, E; Bagnato, A; Cimino, Giuseppe; Mazzucconi, Maria Gabriella; Latagliata, R.

PREDICTIVE FACTORS FOR INFECTIOUS ADVERSE EVENTS IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA TREATED WITH BENDAMUSTINE-RITUXIMAB (R)+/- R MAINTENANCE. RESULTS OF A RETROSPECTIVE ANALYSIS

2017 - HAEMATOLOGICA22nd Congress of the European-Hematology-Association

DI ROCCO, Alice; DE ANGELIS, Federico; Petrucci, L; Vozzella, F; De Benedittis, D; Foa, Roberto; Martelli, Maurizio

REGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL

2017 - HAEMATOLOGICAREGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL

Martini, V; Molfetta, R; Severin, F; Trimarco, V; Frezzato, F; Raggi, F; Martinello, L; Visentin, A; Scomazzon, E; Facco, M; Semenzato, G; Paolini, R; Trentin, L.